VILELLA, ANTONIETTA
 Distribuzione geografica
Continente #
NA - Nord America 7.048
AS - Asia 3.780
EU - Europa 3.181
SA - Sud America 558
Continente sconosciuto - Info sul continente non disponibili 138
AF - Africa 99
OC - Oceania 10
Totale 14.814
Nazione #
US - Stati Uniti d'America 6.813
SG - Singapore 1.115
IT - Italia 1.064
CN - Cina 1.005
GB - Regno Unito 932
BR - Brasile 433
HK - Hong Kong 428
VN - Vietnam 414
DE - Germania 211
SE - Svezia 209
BD - Bangladesh 203
FI - Finlandia 144
KR - Corea 140
RU - Federazione Russa 132
CA - Canada 120
FR - Francia 101
TR - Turchia 96
IN - India 90
UA - Ucraina 85
ID - Indonesia 58
MX - Messico 55
AR - Argentina 46
NL - Olanda 46
BG - Bulgaria 42
ZA - Sudafrica 39
ES - Italia 35
JP - Giappone 34
LT - Lituania 28
IQ - Iraq 27
IE - Irlanda 26
EC - Ecuador 22
PL - Polonia 22
BE - Belgio 20
PK - Pakistan 20
CL - Cile 19
CO - Colombia 18
AT - Austria 16
AE - Emirati Arabi Uniti 15
UZ - Uzbekistan 15
MY - Malesia 14
RO - Romania 12
IR - Iran 11
JO - Giordania 10
PH - Filippine 10
TN - Tunisia 10
AU - Australia 9
CZ - Repubblica Ceca 9
HN - Honduras 9
IL - Israele 9
NO - Norvegia 9
SA - Arabia Saudita 9
DZ - Algeria 8
EU - Europa 8
JM - Giamaica 8
TH - Thailandia 8
CU - Cuba 7
EG - Egitto 7
KE - Kenya 7
KZ - Kazakistan 7
MA - Marocco 7
VE - Venezuela 7
AN - Antille olandesi 6
CH - Svizzera 6
DO - Repubblica Dominicana 6
LB - Libano 6
NP - Nepal 6
PY - Paraguay 6
AL - Albania 5
AZ - Azerbaigian 5
CR - Costa Rica 5
PA - Panama 5
PT - Portogallo 5
TW - Taiwan 5
AO - Angola 4
BO - Bolivia 4
OM - Oman 4
SN - Senegal 4
BH - Bahrain 3
CI - Costa d'Avorio 3
ET - Etiopia 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
AG - Antigua e Barbuda 2
AM - Armenia 2
BB - Barbados 2
BY - Bielorussia 2
EE - Estonia 2
GR - Grecia 2
HU - Ungheria 2
KH - Cambogia 2
KW - Kuwait 2
MD - Moldavia 2
NI - Nicaragua 2
PR - Porto Rico 2
TG - Togo 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
BA - Bosnia-Erzegovina 1
Totale 14.665
Città #
Ashburn 824
Southend 679
Santa Clara 651
Singapore 608
Fairfield 471
Hong Kong 421
San Jose 421
Chandler 384
Hefei 371
Woodbridge 293
Council Bluffs 232
Houston 218
Seattle 214
Modena 211
Beijing 202
Chicago 184
Ann Arbor 179
Wilmington 174
Los Angeles 159
Cambridge 152
Dearborn 141
Ho Chi Minh City 138
Nyköping 135
London 130
Seoul 128
Jacksonville 127
New York 107
Helsinki 105
Hanoi 94
The Dalles 84
Milan 70
Bologna 62
Como 55
Munich 51
Izmir 46
São Paulo 45
Buffalo 44
Lauterbourg 43
Princeton 42
Rome 42
Salt Lake City 42
Jakarta 40
Sofia 40
Dallas 37
San Diego 37
Moscow 35
Eugene 33
Parma 32
Columbus 31
Orem 31
Toronto 29
Chennai 28
Reggio Emilia 28
Redwood City 26
Tokyo 26
Frankfurt am Main 24
Brooklyn 23
Kocaeli 22
Mexico City 22
Phoenix 22
Shanghai 22
Boardman 21
Da Nang 21
Guangzhou 21
Montreal 20
Boston 19
Johannesburg 19
Atlanta 18
Warsaw 18
Dublin 17
Elk Grove Village 17
Fremont 17
Tampa 17
Haiphong 16
Stockholm 16
Madison 15
Brussels 14
Poplar 14
Amsterdam 13
Brasília 13
Bremen 13
Correggio 13
Manchester 13
Quito 13
Tashkent 13
Washington 13
Lancaster 12
Naples 12
Redondo Beach 12
Sterling 12
Tulare 12
Zhengzhou 12
Baghdad 11
Nuremberg 11
Kent 10
Miami 10
Norwalk 10
Ottawa 10
Santiago 10
Turku 10
Totale 9.925
Nome #
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 445
Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC–MS/MS) method for the determination of cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD 436
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 412
Activity and circadian rhythm influence synaptic Shank3 protein levels in mice 392
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 376
Serum protein changes in a rat model of chronic pain show a correlation between animal and humans 374
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 374
LPS-induced histone H3 phospho(Ser10)-acetylation(Lys14) regulates neuronal and microglial neuroinflammatory response 373
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 372
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 367
Heterosynaptic GABAergic plasticity bidirectionally driven by the activity of pre- and postsynaptic NMDA receptors 348
Distribution and relative abundance of S100 proteins in the brain of the APP23 Alzheimer’s disease model mice 347
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 342
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 339
Untargeted rat brain metabolomics after oral administration of a single high dose of cannabidiol 337
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 329
In vivo study of the role of a6-containing nicotinic acetylcholine receptor in retinal function using subtype-specific RDP-MII(E11R) toxin 328
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 326
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 320
Astrocyte-targeted production of IL-10 induces changes in microglial reactivity and reduces motor neuron death after facial nerve axotomy 307
DAT atypical inhibitors as novel antipsychotic drugs 307
A regional and cellular analysis of the early intracellular and extracellular accumulation of Aβ in the brain of 5XFAD mice 293
Neuronal and extraneuronal nicotinic acetylcholine receptors 292
Brain targeting by engineered nanoparticles 281
Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidence 279
Nanoparticles and the BBB crossing: in vivo and in vitro upcomings 274
Bioresorbable Nanostructured Chemical Sensor for Monitoring of pH Level In Vivo 273
PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice 271
Nanomedicine in Neuroscience: the potential of targeted nanoparticles in crossing the Blood-Brain Barrier 269
Melanocortin receptor agonist NDP-α-MSH improves cognitive deficits and microgliosis but not amyloidosis in advanced stages of AD progression in 5XFAD and 3xTg mice 264
Nano-Neuroscience: Targeted nanoparticles For CNS drug delivery 262
Nanotechnology and Central Nervous System Drug Delivery 259
PCSK9 Affects Astrocyte Cholesterol Metabolism and Reduces Neuron Cholesterol Supplying In Vitro: Potential Implications in Alzheimer’s Disease 242
Alterations in microglial phenotype and hippocampal neuronal function in transgenic mice with astrocyte-targeted production of interleukin-10 241
Rab5-dependent cell-specific uptake and distribution of engineered nanoparticles for CNS targeted drug delivery in vivo 238
Nanomedicine in Neuroscience: The potential of targeted nanoparticles in neurodegenerative disorders 216
Female mice exhibit similar long-term plasticity and microglial properties between the dorsal and ventral hippocampal poles 214
S100B dysregulation during brain development affects synaptic SHANK protein networks via alteration of zinc homeostasis 207
Dorsal and ventral striatal neuronal subpopulations differentially disrupt male mouse copulatory behavior 202
Identification of a Thyroid Hormone Derivative as a Pleiotropic Agent for the Treatment of Alzheimer’s Disease 194
Implantable and Bioresorbable Nanostructured Fluorescence Sensor for In vivo pH Monitoring 192
Nanomedicine in neurodegenerative disorders: Understanding the journey 184
MicroRNA-218 instructs proper assembly of hippocampal networks 183
Targeting Metal Homeostasis as a Therapeutic Strategy for Alzheimer’s Disease 183
Hydroxypropyl-β-Cyclodextrin Depletes Membrane Cholesterol and Inhibits SARS-CoV-2 Entry into HEK293T-ACEhi Cells 175
Evidence for a protective effect of the loss of α4-containing nicotinic acetylcholine receptors on Aβ-related neuropathology in Tg2576 mice 163
Long-term behavioral and histological profile following CA3 ventral lesion 150
Two minimally invasive strategies to implant guide cannulas for multiple injections in deep brain areas 150
Placebo effect between evidence and myths: How to distinguish true from fake news 146
Targeted metabolomics for the analysis of p-cresol in mouse brain by HPLC-ESI-MS/MS 145
The Role of Trace Metals in Alzheimer’s Disease 140
Identification of 4-amino-2-Pyridones as new potent PCSK9 inhibitors: From phenotypic hit discovery to in vivo tolerability 139
Targeted Metabolomics for the Analysis of p-Cresol in Mouse Brain: Impact of Biological Sex and Strain 139
Targeted metabolomics for the analysis of p-Cresol in mouse brain by HPLC-ESI-MS/MS 134
Una nuova strategia per ingannare la barriera emato-encefalica: studio in vivo di captazione, distribuzione e trasporto di nanoparticelle nel cervello. 94
Reference gene variability across age and sex in 5XFAD mice highlights normalization challenges in Alzheimer’s models 48
Thermally Degradable Biocompatible Hydrogel as Transient Encapsulation Coating for Implantable Sensors 39
Multiparametric Bioresorbable Sensor for Doxorubicin Detection via Molecularly Imprinted Synthetic Receptors 32
DevelopmentofaBiodegradableGreenEmitterChitosan-Based OLEDfor ImplantableBiomedicalDevices 29
In vivo and in situ monitoring of doxorubicin pharmacokinetics with an implantable bioresorbable optical sensor. 27
Totale 14.814
Categoria #
all - tutte 58.929
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.929


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022761 0 0 87 38 28 37 33 67 101 78 170 122
2022/2023959 104 128 93 90 104 106 13 103 110 15 50 43
2023/2024696 29 33 59 77 149 51 64 78 16 15 48 77
2024/20252.626 95 26 56 160 434 368 222 162 212 194 353 344
2025/20265.562 394 202 382 672 958 322 562 256 533 522 493 266
2026/2027651 209 305 137 0 0 0 0 0 0 0 0 0
Totale 14.814